These Deals Strengthen Our Portfolio: Novartis CEO

These Deals Strengthen Our Portfolio: Novartis CEO Play

April 22 (Bloomberg) –- In a First on Bloomberg Interview, Novartis CEO Joe Jimenez discusses his company’s deals to buy Glaxo’s cancer-drug assets for $16B while selling it’s animal-health operation to Eli Lilly for $5.4B in an overhaul of the company. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus